menu ☰
menu ˟

FDA approves Stelara for treating adolescents with psoriasis

13 Oct 2017
Janssen Biotech Inc. announced in a press release that the FDA has approved an expanded indication of Stelara for treating adolescents aged 12 years or older with moderate-to-severe plaque psoriasis who are candidates for phototherapy or systemic the...

Click here to view the full article which appeared in Dermatology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.